|
|
Document ActionsNovartis hopes success with malaria will aid second drug
by
—
last modified
Dec 05, 2008
Novartis, the Swiss pharmaceutical group, plans to use likely US approval of its malaria medicine Coartem to ease the regulatory pain and boost the profits of another...
Source available
here
|
|
Forgotten your Password?
Register?
